The Outlook for Pharmaceuticals in Latin America

The Outlook for Pharmaceuticals in Latin America published by Espicom Business Intelligence. This annual information service price starts from US $ 3630.

Introduction

Summary

Strong pharmaceutical market growth opportunities and regulatory developments are making Latin America more attractive

Description

Strong pharmaceutical market growth opportunities and regulatory developments are making Latin America more attractive

The region needs to increase drug access, in spite of intensifying cost-containment measures. Therefore, attractive opportunities for (bio)pharmaceutical producers exist in Latin America. Brazil has the largest pharmaceutical market. Strong economic performance will fuel pharmacy sales growth in the forecast period. Mexico is the second leading market. Recent regulatory developments will create further market opportunities in the country, particularly for generic producers in both the private and public sectors. In Argentina, the pharmaceutical industry is expected to perform well in the coming years, with strong growth in production, sales, exports and employment. Pharmaceutical companies, however, are encouraged to act in smaller Latin American markets to maximise their full regional sales potential.

Generics consumption in Latin America is low, with the exception of Brazil which has a dynamic bioequivalent generic sector. In the last two years, foreign producers have penetrated what, until then, had been considered a tough sector due to local protectionism and low prices. Major developments include Pfizer's purchase of 40.0% of Teuto in November 2010, Valeant's acquisitions of two generic producers in the first half of 2010, and Sanofi's acquisition of the largest local generic company Medley in 2009. As a result, multinationals represented over 40.0% of the generic sector in 2010, compared to 12.0% in 2008. This wave of acquisitions is a blow for the government, which aims to create a leading local pharmaceutical group able to compete internationally.

In Mexico, the number of people accessing public healthcare will increase as the country is implementing universal health coverage, which means that some private pharmacy consumption will be transferred to the increasingly attractive public sector. Growth in the private pharmacy sector, therefore, is expected to be more moderate in the forecast period. Fuelled by the current economic slowdown and new regulatory measures, generics penetration in the pharmacy sector will increase and contain the private pharmacy sector by value. Strategically, Sanofi already acquired the local generic producer Kendrick in 2009, whilst Valeant acquired Tecnofarma. The amount of opportunities will be squeezed but the pharmaceutical market is large enough to be attractive in the long-term.

THESE REPORTS ANALYSE THE ISSUES

The Outlook for Pharmaceuticals in Latin America is a unique collection of management reports from Espicom Business Intelligence. Each report provides individual and highly-detailed analysis of each market, looking at the key regulatory, political, economic and corporate developments in the wider context of market structure, service and access. The reports are available individually, or as a discounted collection, and prices include 4 completely updated reports sent quarterly, together with a comprehensive statistical appendix. There are over 60 markets covered in the worldwide series.

HIGHLIGHTS FROM THE REGION...

ARGENTINA

There are over 200 pharmaceutical companies operating in the pharmacy sector, of which over half are Argentine. Local producers dominate the pharmacy sector, led by Roemmers, Bago, Gador and Elea. Recent significant developments include the agreement to start the construction of the Polo Farmaceutico de Buenos Aires, signed by 13 local companies in October 2011; Roemmers' acquisition of 50.0% of a small local OTC company, reported in July 2011; and Roemmers' two-year agreement to distribute and sell 26 primary care products from a Swiss company, announced in January 2011. Mexico and Brazil offer more incentives for multinationals to set up their regional subsidiaries, but two foreign companies made recent strategic acquisitions in the Argentine oncology market in QIII 2011. Previously, GSK acquired Laboratorios Phoenix in June 2010.

BRAZIL

The Brazilian pharmaceutical market ranks first in the Latin American region. Pharmaceutical demand will continue to rise, fuelled by increasing disposable income, therefore the market outlook is positive for the 2011-2016 period. Generics are expected to have a pharmacy market share of 20.0% by value and 25.0% by volume in 2011. Competition among the five leading pharmacy chains is fierce, and the sector has been consolidated by a recent wave of mergers. In September 2011, Drogaria Sao Paulo, the leader in the state of Sao Paulo, and Drogarias Pacheco, the leader in Rio de Janeiro, announced a merger, creating what will be the largest pharmacy chain in Brazil, DPSP. This merger took place after the merger between Drogasil and Droga Raia, announced in August 2011, creating the second largest pharmacy chain, Raia Drogasil.

CHILE

The Chilean pharmaceutical market is expected to increase by a moderate CAGR in US dollar terms between 2011 and 2016. In July 2011, the Institute of Public Health in Chile (ISPCH - Instituto de Salud Publica de Chile) confirmed that it had sent the project to create a National Medicines Agency (ANAMED - Agencia Nacional de Medicamentos) to the Congress. The new agency is expected to update the regulation of medicines, strengthen ISPCH's regulatory functions and implement a number of measures to increase the competitiveness of the pharmaceutical industry. The creation of ANAMED is part of President Sebastian Pinera's National Policy of Medicaments that aims to ensure that medicaments sold in Chile meet efficacy, safety and equivalence standards. The industry believes that the creation of ANAMED could speed up the pharmaceutical registration process.

COLOMBIA

The pharmaceutical market in Colombia is the fourth smallest pharmaceutical market in the Latin American region. The market is set to expand at a one-digit CAGR in dollar terms between 2011 and 2016. The economic and political environment is stable, therefore the outlook is positive for pharmaceutical market growth. Colombia is looking to increase drug access for the whole population under the universal insurance programme (SGSSS), which should expand the market accordingly. Pharmaceutical imports and exports will increase. The number of pharmaceutical companies operating in the market has also risen. Gross pharmaceutical production will continue its upward trend and the industry is expected to create more employment. The leading pharmaceutical company is Tecnoquimicas, followed by Baxter, Roche, Abbott and Bayer. In February 2011, Nycomed, now acquired by Takeda, announced the acquisition of a local company.

CUBA

The economy is expected to do well in the 2011-2016 period, and the Economist Intelligence Unit (EIU) believes that mid-term economic policy is expected to be focused on making the economic system more flexible and promoting more private initiatives. The Cuban pharmaceutical market is the smallest in the Latin American region but, based on current research, production and trade trends, Espicom projects a moderate CAGR in dollar terms between 2011 and 2016. The Cuban pharmaceutical market increased in value by five times in the 1995-2010 period. Cuba has developed a well-established pharmaceutical industry based on the formulation or manufacturing of generic medicines. An important Cuban biotechnology industry has also been developed. The government is responsible for domestic production, which represents between 80% and 90% of the market.

MEXICO

Generic sales in Mexico are still negligible in the private pharmacy sector. However, the National Association of Interchangeable Generic Medicines (AMEGI) believes that consumption of generic medicines in the private pharmacy sector will increase considerably in the forecast period. A number of patents for bestselling drugs will expire in the coming years, and this will accelerate generic market growth. Generic sales are high, when considering sales in the public sector. The public sector is accountable for about 80.0% of generic sales by value, whilst the private pharmacy sector represents the remaining 20.0%; generic sales represented 3.5% of pharmacy sales. In terms of competition, a number of foreign producers, i.e. Sanofi and Valeant, have acquired a couple of local producers, whilst others have formed partnerships with local producers.

PERU

The Peruvian pharmaceutical market is the second smallest in the region. The market is expected to increase by a moderate CAGR in dollar terms between 2011 and 2016. Pharmaceutical expenditure per capita is the lowest in the region. This means that there are growth opportunities, as the economy is expected to perform well in the forecast period. The market increased five times between 1995 and 2010. In January 2011, the Israeli company Teva Pharmaceutical Industries announced that it was acquiring Infarmasa from The Rohatyn Group (TRG) and Altra Investments. Teva commented that the combination of Medco, which is Teva's existing operation in Peru, and Infarmasa would create one of the top two pharmaceutical companies in the country.

VENEZUELA

Inflation rates are expected to remain extremely high in the forecast period, over-inflating the Venezuelan pharmaceutical market in local terms. GDP growth, particularly from 2012 onwards, and population growth are expected to encourage pharmaceutical sales, in spite of drug price controls and currency exchange controls. MPPS will continue to implement Barrio Adentro, but threats in the public sector include government drug imports from countries that co-operate with Venezuela and government pharmaceutical production. Espicom projects the Venezuelan market to rank as the fourth largest in the Latin American region in 2016. OTC and generic sales are expected to increase in the forecast period. There are about 33 pharmaceutical producers, most of which are local. Foreign producers have consolidated their regional operations in other countries in the last ten years, but Bayer, Daiichi Sankyo, Pfizer, Sanofi, La Sante and Teva remain.

Table of Contents

Argentina

EXECUTIVE SUMMARY

Introduction

• Pharmaceutical Market Analysis
• Political & Economic Analysis

Pharmaceutical Market Analysis

• Size
• Market Structure
  • Pharmacy Sector
    • Generic Medicines
  • Public Sector
    • Public Expenditure on 'Special' Medicines
• Projections & Outlook
• Imports
• Manufacturing
  • Production
    • Private Production
    • Public Production
  • Trade Associations
    • CAEMe
    • CAPDROFAR
    • CAPEMVeL
    • CAPGEN
    • CILFA
    • COOPERALA
  • Trade Fairs
    • ETIF
    • EXPOFARMACIA
    • Local Manufacturers
    • Bago
    • Baliarda
    • Bernabo
    • Beta
    • Casasco
    • Craveri
    • Elea
    • Fabop
    • Fada Pharma
    • Gador
    • Gramon
    • Lazar
    • Phoenix
    • Richet
    • Richmond
    • Roemmers
    • Sidus
  • Multinational Manufacturers
  • Bayer
  • Boehringer Ingelheim
  • Eli Lilly
  • Ferring - Dupomar
  • GlaxoSmithKline
  • Pfizer
  • Sandoz
  • Sanofi Pasteur
  • TechSphere
  • Teva-Tuteur
• Exports
• Research & Development

Pharmaceutical Regulatory Analysis

• Pharmaceutical Registration
• Advertising
• Pricing
  • Taxes
• Intellectual Property

Pharmaceutical Distribution Analysis

• Wholesaling
  • Distributors
    • Disprofarma
    • Drogueria del Sud
    • Farmanet
    • Globalfarm
    • Rofina
• Retailing
  • Pharmacy Chains
    • Farmacias del Dr Ahorro
    • Farmacias de Similares
    • Farmacity
    • Vantage

Healthcare Analysis

• Demographics
  • Population
    • Birth Rate
    • Death Rate
    • Infant Mortality
    • Life Expectancy at Birth
  • Public Health
    • Causes of Death
    • Incidence of Communicable Diseases
• Healthcare System
  • New Credit from the World Bank
  • Strengthening the Basic Healthcare Strategy Project
  • Essential Public Health Functions & Programmes Project
  • Provincial Maternal - Child Health Investment Project - Second Phase
  • Primary Healthcare Reform Project
  • Health Insurance
    • Obras Sociales
    • Prepagas
• Health Expenditure
• Healthcare Infrastructure
  • Hospital Resources
    • Private Hospital Associations
  • Inpatient Activity Analysis
  • Outpatient Resources
  • Outpatient Activity Analysis
• Healthcare Personnel

DIRECTORY

• Government Organisations
• Trade Associations

Methodology & Sources

List of Tables

• Summary of Key Data Projections, 2009-2014
• Summary of the Pharmaceutical Market at Retail Prices, 2009
• Pharmaceutical Sales, 2001-QII 2009 (Million Pesos)
• Pharmaceutical Sales, 2001-QII 2009 (US$ Million)
• Pharmaceutical Sales by ATC Classification, QII 2005-2009 (Million Pesos)
• Pharmaceutical Sales by Country, QII 2005-2009 (Million Pesos)
• Pharmacy Sector, November 2008
• Pharmacy Sector by Leading Supplier, November 2008
• Pharmacy Sector by Value, 1994-2007
• Pharmacy Sector, 2007
• Pharmacy Sales Value by Patent Status, 2002-2006 (%)
• Pharmacy Sales Volume by Patent Status, 2002-2006 (%)
• APE's Expenditure, 1999-2006 (Million Pesos)
• Pharmaceutical Market Projections, 2009-2014
• SWOT Analysis of the Argentine Pharmaceutical Market, 2009
• Espicom Analysis of the Argentine Pharmaceutical Market, 2009
• Pharmaceutical Imports by Category, 2003-2007 (US$000s)
• Pharmaceutical Import Trends by Category, 2006-2007 (US$000s)
• Leading Suppliers of Raw Materials, 2007 (US$000s)
• Leading Suppliers of Antisera & Vaccines, 2007 (US$000s)
• Leading Suppliers of Medicaments, 2007 (US$000s)
• Domestic Production of Pharmaceuticals, 2001-QII 2009 (Million Pesos)
• Domestic Production of Pharmaceuticals, 2001-QII 2009 (US$ Million)
• Other Pharmaceutical Production Indicators, 2008
• Pharmaceutical Producers by Location, 2008 (%)
• Manufacturing Plants Purchased by Local Producers, 2000-2006
• Members of CAEMe, 2007
• Members of CAPDROFAR, 2007
• Members of CAPEMVeL, 2007
• Members of CAPGEN, 2007
• Members of CILFA, 2007
• Members of COOPERALA, 2007
• Pharmaceutical Exports by Category, 2003-2007 (US$000s)
• Pharmaceutical Export Trends by Category, 2006-2007 (US$000s)
• Destinations of Pharmaceuticals, 2007 (US$000s)
• Pharmaceutical R&D Investment, 2001-2007
• Product Registration, Annex I & II Listed Countries
• Taxes Paid by the Pharmaceutical Industry by Type, 2005-2006 (Million Pesos)
• Projected Population, 2009-2014
• Summary of Demographic Data, 2007/08
• Members of ADEMP, 2008
• Members of CIMARA, 2008
• Projected Health Expenditure, 2009-2014
• Estimated Healthcare Expenditure, 2008
• Hospitals & Beds, 2000
• Hospital Bed Projections, 2009-2014
• Projected Number of Doctors, 2009-2014

List of Figures

• Pharmaceutical Sales by ATC Classification, QII 2009 (%)
• Pharmaceutical Sales by Leading Country, QII 2009 (%)
• Radar Graph of the Argentine Pharmaceutical Market, 2009
• Pharmaceutical Imports, 1995-2007 (US$ Millions)
• Pharmaceutical Imports by Category, 2007 (%)
• Leading Suppliers of Pharmaceuticals, 2007 (%)
• Pharmaceutical Exports, 1995-2007 (US$ Millions)
• Pharmaceutical Exports by Category, 2007 (%)
• Balance of Trade in Pharmaceuticals, 1995-2007 (US$ Million)

Brazil

EXECUTIVE SUMMARY

Introduction

• Pharmaceutical Market Analysis
• Pharmaceutical Regulatory Analysis
• Pharmaceutical Distribution Analysis
• Healthcare Analysis
• Economic Analysis
• Political Analysis
• Geographic Analysis

Pharmaceutical Market Analysis

• Current Size
• Market Structure
  • Pharmacy Sector
  • Generic Sector
  • OTC Sector
  • Public Sector
• Projections & Outlook
• Imports
• Manufacturing
  • Trade Associations
    • ABIMIP
    • ALANAC
    • ALFOB
    • FEBRAFARMA
    • INTERFARMA
    • Pro-Genericos
  • Trade Fairs
    • ABRADILAN FARMA & HPC
    • ECONOFARMA
    • EXPO FARMACIA
    • EXPO PHARMA
    • FCE PHARMA
    • Hospitalar
    • SHOPFARMA
    • TOPFARMA
  • Local Manufacturers
    • Ache
    • Americano
    • Cimed
    • CPPI
    • Cristalia
    • EMS
    • Eurofarma
    • FURP
    • Hemobras
    • Hipolabor
    • LAFEPE
    • Libbs Farmaceutica
    • Mantecorp
    • Neo Quimica
    • Prati-Donaduzzi
    • Uniao Quimica
    • Multinational Manufacturers
    • AstraZeneca
    • Bayer
    • Boehringer Ingelheim
    • Daiichi-Sankyo
    • GlaxoSmithKline
    • Johnson & Johnson
    • Merck
    • Merck Sharp & Dohme
    • Novartis
    • Novo Nordisk
    • Nycomed
    • Pfizer
    • Roche
    • sanofi-aventis
    • Servier
    • Zambon
    • Zydus Cadila
• Exports
• Research & Development

Pharmaceutical Regulatory Analysis

• MERCOSUR Regulation
• National Regulation
  • Registration
  • Exemptions
• Imports
• Clinical Trials
• Generics
• Labelling & Packaging
• Quality Control
• Traceability
• Advertising
• Pharmacies
  • Regulation of Dispensing Practices
• Pricing & Reimbursement
  • Pricing
  • Reimbursement
    • Farmacia Popular do Brasil
• Intellectual Property Rights
  • Patent Rejection of Tenofovir
  • Compulsory Licence for Efavirenz

Pharmaceutical Distribution

• Wholesaling
  • Distribution Trade Associations
    • ABAFARMA
    • ABRADILAN
  • Distributors
    • Athos Farma
    • Panpharma
    • Profarma
    • Santa Cruz
• Retailing
  • Pharmacy & Drugstore Chains
  • Pharmacy Chain Associations
    • ABRAFARMA
    • ASSIFARMA
    • FEBRAFAR
  • Pharmacy Chains
    • Drogamed
    • Droga Raia
    • Drogaria Araujo
    • Drogaria Sao Paulo
    • Drogarias Pacheco
    • Drogasil
    • Drogasmil
    • Farmacias Pague Menos
    • Panvel Farmacias

Healthcare Analysis

• Demographics
  • Population
    • Birth Rate
    • Death Rate
    • Infant Mortality
    • Life Expectancy at Birth
  • Public Health
    • Causes of Death
    • Incidence of Communicable Diseases
    • Incidence of Non-Communicable Diseases
    • Vaccination
• Healthcare System
  • Second Disease Surveillance & Control Project
  • Bahia Health System Reform Project
• Health Insurance
• Health Expenditure
  • Public Health Expenditure
    • Federal Health Expenditure
• Healthcare Infrastructure
  • Healthcare Establishments
  • Healthcare Resources
• Healthcare Activity
  • Inpatient Care Analysis
  • Ambulatory Care Analysis
• Healthcare Personnel

Directory

• Government Organisations
• Trade Associations

Methodology & Sources

List of Tables

• Summary of Key Data Projections, 2009-2014
• Summary of the Brazilian Pharmaceutical Market, 2009
• Pharmaceutical Market, 1997-2009
• Pharmaceutical Market Value by Month, 2000-2009 (R$ Million)
• Pharmaceutical Market Value by Month, 2000-2009 (US$ Million)
• Pharmaceutical Market Volume by Month, 2000-2009 (Million Units)
• Pharmacy Sector by Value & Volume, 2001-2008
• Generic Pharmacy Sales by Value & Volume, 2000-2008
• Pharmaceutical Market Projections, 2009-2014
• SWOT Analysis of the Brazilian Pharmaceutical Market, 2009
• Espicom Analysis of the Brazilian Pharmaceutical Market, 2009
• Pharmaceutical Imports by Category, 2003-2007 (US$000s)
• Pharmaceutical Import Trends by Category, 2006-2007 (US$000s)
• Leading Suppliers of Raw Materials, 2007 (US$000s)
• Leading Suppliers of Antisera & Vaccines, 2007 (US$000s)
• Leading Suppliers of Medicaments, 2007 (US$000s)
• Pharmaceutical Manufacturing Units by Leading State, 2002-2007
• Pharmaceutical Workforce by Leading State, 2002-2007
• Pharmaceutical Gross Production by Leading State, 2002-2007 (R$ Million)
• Pharmaceutical Gross Production by Companies with 30+ Employees, 2007 (R$ 000s)
• Pharmaceutical Gross Production by Manufacturing Units with 30+ Employees, 2007 (R$ 000s)
• Members of ABIMIP, 2008
• Members of ALANAC, 2008
• Members of ALFOB, 2008
• Members of FEBRAFARMA, 2008
• Members of INTERFARMA, 2008
• Members of Pro-Genericos, 2008
• Cimed's Sales, 2004-2007
• LAFEPE's Product Lines, 2007
• Libbs' Pharmaceutical Sales, 2000-2006
• AstraZeneca's Sales by Sector, 2005-2007 (R$ Million)
• Boehringer Ingelheim's Key Indicators, 2002-2008
• Novartis' Sales by Division, 2006-2007 (R$ Million)
• Roche's Gross Sales, 2006-2008
• Medley's Pharmacy Sales by Value, 2003-2007
• Medley's Generic Sales by Volume, 2003-2007
• Leading Generic Producers by Market Share Value, 2005-2007
• Zambon's Sales, 2005-2008
• Pharmaceutical Exports by Category, 2003-2007 (US$000s)
• Pharmaceutical Export Trends by Category, 2006-2007 (US$000s)
• Leading Destinations of Raw Materials, 2007 (US$000s)
• Leading Destinations of Medicaments, 2007 (US$000s)
• Pharmaceutical Investments by Type, 2007
• Members of ABAFARMA, 2008
• Members of ABRAFARMA, 2008
• Members of ASSIFARMA, 2008
• Members of FEBRAFAR by Region, 2008
• Drogasil's Sales, 2004-2008 (R$ Million)
• Pague Menos' Sales, 2005-2008
• Projected Population, 2009-2014
• Summary of Projected Demographic Data, 2009
• Health Insurers, 2000-2008
• Beneficiaries with Medical Services (With/Without Odontology) by Contract Type, 2000-2008
• Projected Health Expenditure, 2009-2014
• Healthcare Establishments by Provider & Type, January 2009
• Healthcare Establishments by Region & Type, January 2009
• Summary of Healthcare Establishments by Type of Service, January 2009
• Hospital Bed Projections, 2009-2014
• Hospitals & Beds, 2009
• Inpatient Beds by Provider & Establishment, February 2009
• Summary of Medical Equipment by Type, February 2009
• Summary of Existing Medical Equipment by Provider & Type, February 2009
• Summary of Existing Medical Equipment by Region & Type, February 2009
• SUS Hospital Admissions by Specialty, 2008
• SUS Hospital Admissions by Provider, 2000-2008
• SUS Hospital Admissions by Region, 2000-2008
• SUS Ambulatory Procedures by Type, 2008
• Approved SUS Ambulatory Procedures by Provider, 2000-2008
• Approved SUS Ambulatory Procedures by Region, 2000-2008
• Projected Number of Physicians, 2009-2014

List of Charts

• Pharmaceutical Market, 1997-2009
• Radar Graph of the Brazilian Pharmaceutical Market, 2009
• Pharmaceutical Imports, 1997-2007 (US$ Millions)
• Pharmaceutical Imports by Category, 2007 (%)
• Leading Suppliers of Pharmaceuticals, 2007 (%)
• Number of Pharmaceutical Producers, 1997-2007
• Pharmaceutical Workforce, 1997-2007
• Pharmaceutical Gross Production, 1997-2007
• Pharmaceutical Gross Production by Manufacturing Type, 2007 (%)
• Pharmaceutical Exports, 1997-2007 (US$000s)
• Pharmaceutical Exports by Category, 2007 (%)
• Leading Destinations of Pharmaceuticals, 2007 (%)
• Balance of Trade in Pharmaceuticals, 1997-2007 (US$ Million)
• Pharmacy Market Share by Retail Type, 2008 (%)

Chile

EXECUTIVE SUMMARY

Introduction

Pharmaceutical Market Analysis

• Size
• Market Structure
  • Pharmacy Sector
  • Hospital Sector
  • Prescribed Medicines
  • Generic Medicines
  • OTC Medicines
    • Draft Law to Sell OTC Medicines Outside Pharmacies
• Projections & Outlook
  • Drug Quality Assessment Loophole Found in 2008
  • Imports
  • Trade Associations
  • ASILFA
  • CAMEVED
  • CANALAB
  • CIF
  • Domestic Production
  • FTA Developments
  • Local Manufacturers
  • Andromaco
    • Financial Indicators
    • Product Portfolio
    • Manufacturing Capabilities
    • Exports
    • International Divisions
  • Bago
    • Financial Indicators
    • Product Portfolio
    • Manufacturing Capabilities
    • Exports
  • Bestpharma
    • Product Portfolio
  • Biosano
    • Financial Indicators
    • Product Portfolio
    • Manufacturing Capabilities
  • LabChile
    • Financial Indicators
    • Product Portfolio
    • Manufacturing Capabilities
    • Exports
    • Distribution
  • Labomed
    • Maver
    • Mintlab
    • Recalcine
    • Financial Indicators
    • Product Portfolio
    • Manufacturing Capabilities
    • Research & Development
  • Sanderson
    • Financial Indicators
    • Product Portfolio
    • Manufacturing Capabilities
    • Exports
  • Saval
    • Financial Indicators
    • Product Portfolio
    • Manufacturing Capabilities
    • Exports
  • Exports
• Research & Development

Pharmaceutical Regulatory Analysis

• Pharmaceutical Regulation
  • Public Consultation on New Pharmaceutical Regulations
• Pharmaceutical Registration
  • Quality Standards
  • Stock Control
  • Legal Proceedings
• Drug Approval Process
• Advertising
• Patent Protection & Intellectual Property Rights
  • China and Chile Agree Customs IP Cooperation Agreement
• Pricing & Reimbursement
• Reimbursement

Pharmaceutical Distribution

• Distribution Developments in the Retail Market
• Pharmacy Own-Labelled Production
• Retail Pharmacy Chains
  • Cruz Verde
  • Farmacias Ahumada
  • Farmacias SalcoBrand
  • FarmaLider
• CENABAST

Healthcare Analysis

• Demographics
  • Population
    • Birth Rate
    • Death Rate
    • Infant Mortality
    • Life Expectancy at Birth
  • Public Health
    • Causes of death
    • Incidence of Communicable Disease
    • Incidence of Non-communicable disease
  • Chileans Suffer From High Rates of Digestive Illness
    • HIV/AIDS
• Healthcare System
• SNSS / FONASA
• Isapres
  • Isapre Changes, Problems and Price Increases
• The Reform
  • Financing Government Expenditure Law
  • Health Authority & Management Law
  • Health Guarantees System Law
  • Private Health Law
  • Rights & Duties Law
• Health Expenditure
  • Health Expenditure Projections
• Healthcare Infrastructure
  • Inpatient Analysis
• Healthcare Personnel
  • Physician Projections

DIRECTORY

• Government Organisations
• Trade Associations

Methodology and Sources

List of Tables

• Summary of Key Data Projections, 2009-2014
• Summary of the Chilean Pharmaceutical Market, 2009
• Market Value by Sector, 1993-2007 (US$ Million)
• Change in US$ Market Value by Sector, 1993-2007 (%)
• Market Value by Sector, 1993-2005 (As % of Total)
• Market Value by Sector, 1993-2002 (Billion Pesos)
• Pharmacy Sector by Value & Volume, 2006
• Pharmacy Sector by Value & Volume, 2005
• Pharmacy Sector by Value & Volume, 2004
• Pharmacy Sector Value by Leading Producers, June 2005 (Million Pesos)
• Pharmacy Sector Value by Leading Producers, June 2005 (US$ Million)
• Pharmacy Sector Value & Volume by Origin of Supplier, March 2005 (%)
• Leading Therapeutic Categories by Value & Volume, 2004 (US$ Million & Million Units)
• Leading Therapeutic Categories, 2004 (Million Units)
• Market Projections at Retail Prices, 2009-2014
• SWOT Analysis of the Chilean Pharmaceutical Market, 2009
• SWOT Analysis of the Chilean Health System, 2009
• Espicom Analysis of the Chilean Pharmaceutical Market, 2009
• Pharmaceutical Imports, 2003-2007 (US$000's)
• Import Trends
• Leading Suppliers of Raw Materials, 2007 (US$000s)
• Leading Suppliers of Medicaments, 2007 (US$000s)
• ASILFA's Members, 2008
• CANALAB's Members, 2008
• CIF's Members, 2008
• Summary of Pharmaceutical Establishments & Workforce, 2000-2005
• Pharmaceutical Establishments & Workforce by Company Size, 2000-2005
• Summary of Pharmaceutical Production, 2000-2005 (Million Pesos)
• Summary of Pharmaceutical Production, 2000-2005 (US$ Million)
• Pharmaceutical Production by Company Size, 2000-2005 (Million Pesos)
• Andromaco's Sales, 2000-2007 (Billion Pesos)
• Biosano's Product Portfolio, 2008
• Pharmaceutical Producers Represented by Labomed, 2007
• Pharmaceutical Exports, 2003-2007 (US$000's)
• Export Trends
• Leading Destinations, 2007 (US$000s)
• Leading Exporters of Pharmaceuticals, 2002-2007(US$ Million)
• Number of Product Registrations, 1999-2006
• Summary Demographic Data 2005-07
• Projected Population, 2009-2014
• Health Beneficiaries, 1990-2008
• Isapres' Beneficiaries, 1990-2007
• Beneficiaries by Isapre Type, 2007
• Major Structural Implementations, 2000-2010
• The Five-Law Reform Bill, 2004
• Total AUGE Programme Patients, October 2007
• AUGE Pilot Programme Patients, August 2002-November 2004
• Healthcare Expenditure, 2006
• Projected Health Expenditure, 2009-14
• Hospitals and Beds, 2005-06
• Hospital Bed Projections, 2009-2014
• Projected Number of Physicians, 2009-14 (000s)

List of Figures

• Pharmacy Sector by Value & Volume, 2005
• Pharmacy Sector by Value & Volume By Supplier's Origin, March 2005
• Radar Graph of the Chilean Pharmaceutical Market, 2009
• Pharmaceutical Imports, 2007 (As % of Total)
• Leading Suppliers, 2007 (%)
• Pharmaceutical Production, 2000-2005
• Andromaco's Sales, 2000-2007
• Saval's Sales, 2003-2006
• Pharmaceutical Exports by Category, 2007 (%)
• Leading Destinations, 2007 (%)
• Leading Exporters of Pharmaceuticals, 2007 (US$ Million)
• Drug Pricing by Product Type, 2002-05 (US$)
• Pharmacy Sector by Distribution Channels, 2006 (%)
• FASA's Sales, 2000-07 (US$)
• Healthcare Institutions' Organisation
• Isapres' Benificiaries, 1990-2007

Colombia

EXECUTIVE SUMMARY

Introduction

Pharmaceutical Market Analysis

• Size
• Market Structure
  • Pharmacy Sector
  • Institutional Sector
  • Prescription Medicines
  • Generics Sector
  • OTC Medicines
• Projections & Outlook
• Imports
• Domestic Manufacturing
  • Domestic Production
  • Trade Associations
    • AFIDRO
    • ANDI
    • ASINFAR
    • CECIF
  • Local Manufacturers
    • America
    • Biogen
    • Beiersdorf
    • California
    • Ecar
    • Fabrifarma
    • Genfar
    • Grupo Ave
    • Lafrancol
    • La Sante
    • Procaps
    • Tecnoquimicas
  • Multinational Manufacturers
    • Baxter
    • Bayer Schering
    • Boehringer Ingelheim
    • Bristol-Myers Squibb
    • GlaxoSmithKline
    • Merck
    • sanofi-aventis
    • Schering Plough
• Exports
• Research & Development
  • Bogota Destination for Phase II-IV Drug trials

Pharmaceutical Regulatory Analysis

• Pharmaceutical Regulation
• Pharmaceutical Registration
  • New Drugs
  • Modifications
  • Renewals
  • Biological Products
• Product Control & Vigilance
• Import Certification
• Advertising
• Patent Protection & Intellectual Property Rights
• Pricing & Reimbursement
  • Drug Pricing
  • Reimbursement

Pharmaceutical Distribution

• Wholesaling
• Retailing

Healthcare Analysis

• Demographics
  • Population
    • Birth Rate
    • Death Rate
    • Infant Mortality
    • Life Expectancy at Birth
  • Public Health
    • Causes of death
    • Incidence of Communicable Disease
    • Incidence of Non-communicable disease
    • Tuberculosis
    • HIV/AIDS
• Healthcare System
• Universal Health Insurance
  • Financial problems
  • Inter-American Development Bank social security projects
• Health Expenditure
  • Health Expenditure Projections
• Healthcare Infrastructure
  • Inpatient Analysis
  • Inter-American Development Bank hospital programme
• Healthcare Personnel
  • Physician Projections

DIRECTORY

• Government Organisations
• Trade Associations

Methodology & Sources

List of Tables

• Summary of Key Data Projections, 2009-2014
• Summary of the Colombian Pharmaceutical Market, 2009
• Pharmaceutical Market, 1995-2004 (US$ Million at 2004 Constant Prices)
• Pharmaceutical Market, 1995-2004 (%)
• Pharmaceutical Market by Sector, 2000-2004 (US$ Million at 2004 Constant Prices)
• Entry Date of Pharmacy Drugs by Sector, 1970-2004 (%)
• Entry Date of Pharmacy Drugs by Origin, 1970-2004 (%)
• Pharmacy Sector by Value at Manufacturers' Prices, 2003 (US$ Million)
• Pharmacy Sector by Value, 1995/2000 (%)
• Market Projections, 2009-2014
• SWOT Analysis of the Colombian Pharmaceutical Market, 2009
• Espicom Analysis of the Colombian Pharmaceutical Market, 2009
• Imports of Pharmaceuticals by Category, 2003-07 (US$000s)
• Import Trends 2007 (US$000s)
• Leading Suppliers of Raw Materials, 2007 (US$000s)
• Leading Suppliers of Medicaments, 2007 (US$000s)
• Pharmaceutical Production by Type, 2005
• Pharmaceutical Production by Type, 2004
• Pharmaceutical Production Indicators, 2004 (US$ Million)
• Pharmaceutical Production, 1995-2004 (At 2004 Constant Prices)
• AFIDRO Members, 2009
• CECIF members, 2009
• Boehringer Ingelheim's Net Sales, 2004-2006
• Exports of Pharmaceuticals, 2003-07 (US$000s)
• Export Trends 2007 (US$000s)
• Leading Destinations, 2007 (US$000s)
• Summary of the USA - Colombian Trade Agreement's Intellectual Property Agreements, 2006
• Drug Pricing Classification, 2005
• Drug Pricing Classification I, 2005 (%)
• Drug Pricing Classification II, 2005 (%)
• Direct Pharmaceutical Sales Distribution Channels, 1999-2003 (%)
• Summary Demographic Data 2005/07
• Projected Population, 2009-2014
• Entities within the Ministry of Social Protection, 2004
• Healthcare Expenditure, 2006
• Projected Health Expenditure, 2009-14
• Hospitals and Beds, 2004
• Hospital Bed Projections, 2009-2014
• Projected Number of Physicians, 2009-14 (000s)

List of Charts

• Pharmaceutical Market, 1995-2004 (US$ Million at 2004 Constant Prices)
• Pharmaceutical Market by Sector, 2000-2004 (%)
• Pharmacy Sector by Value, 2003 (%)
• Essential Medicines in the Pharmacy Prescription Sector, 1994-2000 (%)
• Radar Graph of the Colombian Pharmaceutical Market, 2009
• Imports by Category, 2007 (%)
• Leading Suppliers, 2007 (%)
• Leading Destinations, 2007 (%)
• Distribution of the Population by Type of Coverage, 2005

Cuba

EXECUTIVE SUMMARY

Introduction

Pharmaceutical Market Analysis

• Size
• Market Structure
  • Generic Medicines
• Projections & Outlook
  • Imports
  • Trade Associations
    • QUIMEFA
    • The Western Havana Bio-Cluster "Scientific Pole"
  • Domestic Production
  • Investments in Pharmaceutical Industry to Boost Production
  • Cuba-Malaysia Biotechnology & Pharmaceutical Co-operation
  • Local Manufacturers
    • Adalberto Pessant
    • CIDEM
    • CIGB (Heber Biotec)
    • CIM (CIMAB)
    • Eron
    • Instituto FINLAY
    • MEDILIP
    • MEDSOL
    • NOVATEC
    • Reynaldo Gutierrez
    • Roberto Escudero Diaz
    • 8 de Marzo
  • Foreign Manufacturers
    • Bioven
    • Genesis Medical Technologies
    • GlaxoSmithKline
    • Exports
• Research & Development

Pharmaceutical Regulatory Analysis

• Pharmaceutical Regulation
• Pharmaceutical Registration & Drug Approval Process
  • Bioavailability & Bioequivalence Trials
  • Registration of Antiretrovirals
• Advertising
• Patent Protection & Intellectual Property Rights
• Pricing & Reimbursement

Pharmaceutical Distribution

• FARMACUBA

Healthcare Analysis

• Demographics
  • Population
    • Birth Rate
    • Death Rate
    • Infant Mortality
    • Cuba Increases Congenital Heart Disease Detection
    • Life Expectancy at Birth
  • Public Health
    • Causes of Death
    • Incidence of Communicable Disease
    • Incidence of Non-communicable Disease
    • New Anti-Cancer Products on Clinical Trial
    • New allergenic vaccines
    • HIV/AIDS
• Healthcare System
• Health Expenditure
  • Health Expenditure Projections
• Healthcare Infrastructure
  • First Child Kidney Transplant Performed in Lucia Clinical Surgical Hospital, Holguin
    • Inpatient Analysis
• Healthcare Personnel
  • Cuba Training Doctors for Work Overseas
  • Cuba Biomaterials Potential?
  • Physician Projections

DIRECTORY

• Government Organisations
• Trade Associations

Methodology and Sources

List of Tables

• Summary of Key Data Projections, 2009-2014
• Summary of the Cuban Pharmaceutical Market, 2009
• List of Essential Medicines (CBM) by Sector & Origin, 2007 & 2009
• List of Essential Medicines (CBM) by Sector & Origin, 2007 & 2009 (%)
• List of Essential Medicines (CBM) by Pharmacy Type & Origin, 2007 & 2009
• List of Essential Medicines (CBM) by Pharmacy Type & Origin, 2007 & 2009 (%)
• Pharmaceutical Market Projections, 2009-2014
• SWOT Analysis of the Cuban Pharmaceutical Market, 2009
• Espicom Analysis of the Cuban Pharmaceutical Market, 2009
• Imports of Pharmaceuticals by Category, 2003-07 (US$000s)
• Import Trends 2007 (US$000s)
• Leading Suppliers, 2007
• Leading Suppliers of Raw Materials, 2007 (US$000s)
• Leading Suppliers of Medicaments, 2007 (US$000s)
• Pharmaceutical Production, 1997-2008 (Million Pesos)
• Leading Domestic Producers in Havana
• Exports of Pharmaceuticals, 2003-07 (US$000s)
• Export Trends 2007 (US$000s)
• Leading Destinations, 2007 (US$000s)
• Leading Destinations of Antisera & Vaccines, 2007 (US$000s)
• Leading Destinations of Medicaments, 2007 (US$000s)
• Clinical Trial Authorisations & Modifications by Product Type, Cumulative 1995-2006*
• Processing Time for Clinical Trial Authorisations & Modifications, 2003-2006
• Clinical Trial Authorisations by Institution, 2001-2003
• Import Certificate Requests & Approvals, 2006
• Registered Antiretrovirals, 2000-03
• Leading Pharmaceutical Product Lines Distributed by FARMACUBA
• Summary Demographic Data 2007
• Projected Population, 2009-2014
• Healthcare Expenditure, 2007
• Projected Health Expenditure, 2009-14
• Hospitals and Beds, 2007
• Hospital Bed Projections, 2009-2014
• Projected Number of Physicians, 2009-14 (000s)

List of Figures

• List of Essential Medicines (CBM) by Sector & Origin, 2007 & 2009
• List of Essential Medicines (CBM) by Pharmacy Type, 2009
• Pharmaceutical Imports, 2007 (As % of Total)
• Leading Suppliers, 2007 (%)
• Pharmaceutical Production, 1997-2008 (Million Pesos)
• Pharmaceutical Exports by Category, 2007 (%)
• Leading Destinations, 2007 (%)
• Drug Registrations, 1990-2007
• Community Pharmacies, 1995-06

Mexico

EXECUTIVE SUMMARY

Introduction

Pharmaceutical Market Analysis

• Size
• Market Structure
  • Private Pharmacy Sector
    • OTC Sector
  • Public Sector
    • Socioeconomic Impact: Influenza A (H1N1)
    • Socioeconomic Impact: HIV/AIDS
  • Generics Sector
    • Medi-Mart
• Projections & Outlook
• Imports
• Domestic Manufacturing
  • Domestic Production
  • Trade Associations
    • AFAMELA
    • AMEGI
    • AMELAF
    • AMIIF
    • ANAFAM
    • ANAPIF
    • CANIFARMA
  • Trade Fairs
    • EXPOFARMA INTERPHEX 2009
    • ExpoSALUD y Bienestar
  • Local Manufacturers
    • Chinoin
    • Genomma Lab
    • IFA Celtics
    • Landsteiner Scientific
    • Liomont
    • Neolpharma
    • Pisa Farmaceutica
    • Probiomed
    • Senosiain
    • Silanes
    • Sophia
    • TechSphere
  • Multinational Manufacturers
    • Armstrong
    • AstraZeneca
    • Bayer
    • Boehringer Ingelheim Promeco
    • Bristol-Myers Squibb
    • Eli Lilly
    • GlaxoSmithKline
    • Merck
    • Merck Sharp & Dohme
    • Novartis
    • Perrigo
    • Pfizer
    • Roche
    • sanofi-aventis
    • Schering-Plough
    • Solvay Pharmaceuticals
    • Teva
    • Valeant
    • Wyeth
• Exports
• Research & Development

Pharmaceutical Regulatory Analysis

• Pharmaceutical Regulation
  • Regulatory Developments for Biologics
  • Regulatory Development for Medical Samples
  • Regulatory Developments for Manufacturing
  • Pharmaceutical Registration
  • Registration Renewals
  • Import Regulations
  • Advertising
• Pricing & Reimbursement
  • Tax Proposal
  • Pricing in the Private Pharmacy Sector
  • Pricing in the Public Sector
  • Reimbursement
• Intellectual Property
• Patent Extensions

Pharmaceutical Distribution

• Wholesaling
  • Distribution Associations
    • DINAMEGI
    • DIPROFAR
  • Distributors
    • Grupo Casa Saba
    • Marzam
    • NADRO
• Retailing
  • Pharmacy Associations
    • ANADIM
    • ANAFARMEX
    • UPROFARM
  • Pharmacy Chains
    • Ahorro
    • Benavides
    • El Fenix
    • Fasi
    • Fragua
    • Similares

Healthcare Analysis

• Demographics
  • Population
    • Birth Rate
    • Death Rate
    • Infant Mortality
    • Life Expectancy at Birth
  • Public Health
    • Causes of Death
    • Incidence of Communicable Diseases
    • Incidence of Non-Communicable Diseases
• Healthcare System
  • Organisation & Administration
    • Stewardship
    • Financial Imbalances
  • Social Security
• Health Expenditure
  • SS Health Expenditure
• Healthcare Infrastructure
  • Hospital Resources Analysis
    • IMSS Hospital Investments
    • SS Hospital Investments
    • ISSSTE ECG Investments
    • Private Hospital Operators
  • Hospital Inpatient Analysis
    • Outpatient Resources Analysis
    • Outpatient Activity Analysis
• Healthcare Personnel

DIRECTORY

• Government Organisations
• Trade Associations

Methodology & Sources

List of Tables

• Summary of Key Data Projections, 2009-2014
• Summary of the Mexican Pharmaceutical Market, 2009
• Private Pharmacy & Public Sectors by Value, 2008 (US$ Billion)
• Market Projections, 2009-2014
• SWOT Analysis of the Pharmaceutical Market, 2009
• Espicom Analysis of the Mexican Pharmaceutical Market, 2009
• Pharmaceutical Imports by Category, 2003-2007 (US$000s)
• Pharmaceutical Import Trends by Category, 2006-2007 (US$000s)
• Leading Suppliers of Raw Materials, 2007 (US$000s)
• Leading Suppliers of Antisera & Vaccines, 2007 (US$000s)
• Leading Suppliers of Medicaments, 2007 (US$000s)
• Pharmaceutical Production Indicators, 1999-2006
• Pharmaceutical Production Breakdown, 2000-2005 (Billion Pesos)
• Members of AFAMELA, 2007
• Members of AMEGI, 2008
• Members of AMIIF, 2008
• Members of ANAFAM, 2007
• Members of CANIFARMA, 2007
• Genomma Lab's Sales, 2005-June 2009
• Genomma Lab's Bestselling Products by Sales, 2008
• AstraZeneca's Sales, 2005-2007
• Novartis Sales by Division, 2007
• Pharmaceutical Exports by Category, 2003-2007 (US$000s)
• Pharmaceutical Export Trends by Category, 2006-2007 (US$000s)
• Leading Destinations of Pharmaceuticals, 2007 (US$000s)
• Clinical Studies, 2003-2006
• Legal Pharmaceutical Registration Requirements
• Technical, Preclinical & Clinical Registration Requirements
• NOM-177-SSA1-1998's Generic Tests
• Time for Registration Approval & Fees
• Registration Renewal Requirements
• Import Fees Applicable from 1st January 2007
• GCS's Sales, 2003-QII 2008
• Members of ANADIM, 2007
• Farmacias Benavides' Figures, 2002-QI 2009
• Corporativo Fragua's Figures, 2002-QI 2009
• Summary of Demographic Data, 2007-2008
• Projected Population, 2009-2014
• Projected Health Expenditure, 2009-2014
• Healthcare Expenditure, 2007
• Hospital Bed Projections, 2009-2014
• Hospitals & Beds, 2008
• Medica Sur's Revenues, 2004-2007 (Million Pesos)
• Hospital Discharges by Sector, 2001-2008 (000s)
• Hospital Surgical Procedures by Sector, 2001-2008 (000s)
• Consulting Rooms by Sector, 2000-2008
• Outpatient Consultations by Sector, 2000-2008 (000s)
• Projected Number of Doctors, 2009-2014
• Doctors by Sector, 2000-2008

List of Figures

• Radar Graph of the Mexican Pharmaceutical Market, 2009
• Pharmaceutical Imports, 1995-2007 (US$ Billions)
• Pharmaceutical Imports by Category, 2007 (%)
• Leading Suppliers of Pharmaceuticals, 2007 (%)
• Pharmaceutical Exports, 1995-2007 (US$ Millions)
• Pharmaceutical Exports by Category, 2007 (%)

Peru

EXECUTIVE SUMMARY

Introduction

Pharmaceutical Market Analysis

• Size
• Market Structure
  • The Pharmacy Sector
  • The Hospital Sector
    • Reverse Auctions
  • Original Medicines
  • Generic Medicines
• Projections & Outlook
• Imports
  • Parallel Imports
• Trade Associations
  • ADIFAN
  • ALAFAL
  • ALAFARPE
  • COMSALUD
• Domestic Production
  • Improved GMP Compliance for Domestic Producers
• Local Manufacturers
  • Farmindustria
  • Hersil
  • Induquimica
  • Infarmasa Corporation
  • Medco Corporation
  • Medifarma
  • Multinational Manufacturers
• Exports
  • Exporters of Medicinal and Pharmaceutical Products, 2009
• Research & Development

Pharmaceutical Regulatory Analysis

• Pharmaceutical Regulation
• Drug Approval Process
• Pharmaceutical Registration
• Advertising
• Patent Protection & Intellectual Property Rights
• Pricing & Reimbursement
• Pharmaceutical Distribution
  • Distributors
  • Retail Pharmacy Chains

Healthcare Analysis

• Demographics
  • Population
    • Birth Rate
    • Death Rate
    • Infant Mortality
    • Life Expectancy at Birth
  • Public Health
    • Causes of death
    • Incidence of Communicable Disease
    • Incidence of Non-communicable disease
    • HIV/AIDS
  • HIV/AIDS Developments
• Healthcare System
  • Universal Health Insurance Law Approved
  • Aid Projects
    • Pipeline World Bank Health Sector Project
  • World Bank' s Health Sector Reform Project, Second Phase Approved
  • Peru' s 2007 Poverty Figures Released, Down 9% since 2004
    • IADB Projects
  • MINSA
  • MINSA Increases Outpatient Consultations by 20% Thanks to Late Shifts
  • ESSALUD
  • FFAA & PNP
  • Non-Public Providers
  • SIS
  • Health Insurance
• Health Expenditure
  • Health Expenditure Projections
• Healthcare Infrastructure
  • 1 Billion Soles for Investment in Hospitals
  • US$10 Million Grant for 50,000 Cataracts Operations in Peru
  • ESSALUD Launches Second Digital Hospital
    • Inpatient Analysis
  • New National Blood Bank
  • Healthcare Personnel
    • Physician Projections
    • Doctors Ongoing Strikes over Pay and Working Conditions

DIRECTORY

• Government Organisations
• Trade Associations

Methodology and Sources

List of Tables

• Summary Key Data Projections, 2009-2014
• Summary of the Peruvian Pharmaceutical Market, 2009
• Market Value at Retail Prices, 2008
• Market Value at Manufacturers' Prices, 2007
• Market Value by Country/Region of Origin, 1999-2003 (%)
• Domestic Producers Rankings by Market Value & Volume, 2003
• International Producers Rankings by Market Value & Volume, 2003
• Economic Concentration by Therapeutic Areas, 1999-2003 (%)
• ESSALUD's Pharmaceutical Expenditure, 2003
• Public Drug Auction Projected Expenditure by Sector, January 2008 (Million Soles)
• Public Drug Auction Expenditure by Sector, December 2006 (Million Soles)
• Public Drug Auction Expenditure by Sector, December 2006 (%)
• Market Projections at Retail Prices, 2009-2014
• SWOT Analysis of the Peruvian Pharmaceutical Market, 2009
• Espicom Analysis of the Peruvian Pharmaceutical Market, 2009
• Pharmaceutical Imports, 2003-2007 (US$000s)
• Import Trends, 2006-2007 (US$000s)
• Leading Suppliers of Raw Materials, 2007 (US$000s)
• Leading Suppliers of Medicaments, 2007 (US$000s)
• Domestic Production at 1994 Constant Prices, 1991-2007
• Exports of Pharmaceuticals, 2003-2007 (US$000s)
• Export Trends, 2006-2007 (US$000s)
• Leading Destinations, 2007 (US$000s)
• Leading Exporters of Pharmaceuticals, 2003-2005 (US$000s)
• DIGEMID's Functions
• Drug Registrations, 2000-August 2004
• Drug Registrations by Origin, 2000-August 2004
• Drug Registrations by Composition, 2000-August 2004
• Drug Registrations by Status, 2000-August 2004
• Drug Registrations by Therapeutic Group, 2000-August 2004
• Pharmaceutical Patents, 1994-2004
• Granted Pharmaceutical Patents by Company, 1994-2004
• Leading Distributors, 2001-2002
• Summary Demographic Data 2005-07
• Projected Population, 2009-2014
• World Bank Contracts Awarded, 2005-06
• Percentage of Poverty by Department, 2007
• Recent IADB Projects
• MINSA's Health Plan, 2002-2012
• ESSALUD's Projects & Expenditure, 2007 & 2008
• Population Affiliated to Health Insurance by Provider, 2004-2008 (% of Total)
• Population Affiliated to SIS by Type, 2002-2006
• Population Affiliated to SIS by Location, 2002-2006
• Population Affiliated to SIS by Health Establishment, 2002-2006
• Healthcare Expenditure, 2006
• Projected Health Expenditure, 2009-14
• Hospitals and Beds, 2005/07
• Hospital Bed Projections, 2009-2014
• Projected Number of Physicians, 2009-14 (000s)

List of Figures

• Market Value at Manufacturers' & Retail Prices, 2004 (%)
• Market Value by Registration Status, 2004 (%)
• Radar Graph of the Peruvian Pharmaceutical Market, 2009
• Domestic Production at Current Prices, 1991-2003
• Drug Registrations by Type of Drug, August 2004 (%)
• Population Affiliated to SIS by Type, 2002-2006 (%)
• Population Affiliated to SIS by Location, 2002-2006 (%)
• Population Affiliated to SIS by Health Establishment, 2002-2006 (%)

Venezuela

EXECUTIVE SUMMARY

Introduction

• Pharmaceutical Market Overview
• Pharmaceutical Regulatory Overview
• Pharmaceutical Distribution Overview
• Healthcare Overview
• Political Overview
• Economic Overview

Pharmaceutical Market Analysis

• Current Size
• Market Structure
  • Private Pharmacy Sector
    • Generics Sector
    • OTC Sector
  • Public Sector
    • Socio-Economic Impact: Influenza A (H1N1)
• Projections & Outlook
• Imports
• Domestic Manufacturing
  • Production
  • Trade Associations
    • CAMESIP
    • CANAMEGA
    • CAVEME
    • CIFAR
  • Trade Fairs
    • CEIFAV
  • Local Manufacturers
    • Behrens
    • Calox Internacional
    • Cofasa
    • Especialidades Dollder
    • Giempi
    • Grupo Farma
    • Kimiceg
    • Leti
    • Meyer
    • Oftalmi
    • Productos Ronava
    • SEFAR
    • Spefar
    • Valmor
    • Vargas
  • Multinational Manufacturers
    • Bayer Venezuela
    • Elmor
    • La Sante
    • Pfizer
    • sanofi-aventis
• Exports
• Research & Development

Pharmaceutical Regulatory Analysis

• Pharmaceutical Regulatory Updates
• Pharmaceutical Registration
• Advertising
• Pricing & Reimbursement
  • Pricing
  • Reimbursement
  • Currency Exchange Controls
• Intellectual Property
• Pharmaceutical Distribution Analysis
• Wholesaling
  • Trade Association
    • CAVEDRO
  • Distributors
    • Corporacion Drolanca
    • Drogueria del Oeste
    • Drogueria Farvenca-Race
    • Drogueria Lider
    • Drogueria Nena
    • Organizacion Comercial Belloso
• Retailing
  • Pharmacy Chain Association
    • CAVEFAR
  • Pharmacy Chains
    • Farmacias SAAS
    • Farmacias Sociales
    • Farmahorro
    • Farmatodo
    • Fundafarmacia
    • Locatel

Healthcare Analysis

• Demographics
  • Population
  • Birth Rate
  • Death Rate
  • Infant Mortality
  • Life Expectancy at Birth
  • Public Health
  • Causes of Death
  • Incidence of Communicable Diseases
  • Vaccination
• Healthcare System
  • MPPS
  • IVSS
  • Metropolitan Public Health System
• Health Expenditure
• Healthcare Infrastructure
  • Hospital Resources
    • Barrio Adentro III
    • Barrio Adentro IV
    • Milagro Mission
  • Inpatient Analysis
  • Ambulatory Resources
    • Barrio Adentro I
    • Barrio Adentro II
  • Ambulatory Activity
• Healthcare Personnel
  • MPPS' Personnel
  • Barrio Adentro's Medical Personnel
  • IVSS' Medical Personnel

DIRECTORY

• Government Organisations
• Trade Associations

Methodology & Sources

List of Tables

• Summary of Key Data Projections, 2009-2014
• Summary of the Venezuelan Pharmaceutical Market, 2009
• Pharmacy & Hospital Sectors at Manufacturers' Prices, 2000-2008 (US$ Billion)
• Pharmacy Sales by Sector, October 2008
• Pharmacy Sales, 2003-2007
• Pharmacy Sales by Sector, 2003-2007
• Pharmacy Sales by Origin, 2007
• Pharmacy Sales by Sector, 2007
• Market Projections at Retail Prices, 2009-2014
• SWOT Analysis of the Venezuelan Pharmaceutical Industry, 2009
• Espicom Analysis of the Venezuelan Pharmaceutical Market, 2009
• Pharmaceutical Imports by Category, 2003-2007 (US$000s)
• Pharmaceutical Import Trends by Category, 2006-2007 (US$000s)
• Leading Suppliers of Raw Materials, 2007 (US$000s)
• Leading Suppliers of Antisera & Vaccines, 2007 (US$000s)
• Leading Suppliers of Medicaments, 2007 (US$000s)
• Members of CAMESIP, 2009
• Members of CAVEME, 2009
• Members of CIFAR, 2009
• Pharmaceutical Exports by Category, 2002-2006 (US$000s)
• Pharmaceutical Export Trends by Category, 2005-2006 (US$000s)
• Leading Destinations of Pharmaceuticals, 2006 (US$000s)
• Registration Requirements
• Renewal Requirements
• Foreign Exchange Authorisations for the Health Sector by Type, 2007-2008 (US$ Million)
• Foreign Exchange Authorisations for the Health Sector by Origin, 2007-2008 (US$ Million)
• Foreign Exchange Authorisations for the Health Sector, 2006-2007 (US$ Million)
• Members of CAVEDRO, 2009
• Members of CAVEFAR, 2009
• Projected Population, 2008-2014
• Summary of Demographic Data, 2007
• Projected Health Expenditure, 2008-2014
• Ministry of Health's Budget, 1998-2008
• Hospitals & Beds
• Hospital Bed Projections, 2008-2014
• Projected Number of Physicians, 2008-2014

List of Charts

• Pharmacy & Hospital Sectors at Manufacturers' Prices, 2000-2008 (US$ Billion)
• Radar Graph of the Venezuelan Pharmaceutical Market, 2009
• Pharmaceutical Imports, 1998-2007 (US$ Million)
• Pharmaceutical Imports by Category, 2007 (%)
• Leading Suppliers of Pharmaceuticals, 2007 (%)
• Pharmaceutical Exports, 1998-2006 (US$ Million)

Related Reports